Paper Details

  1. Home
  2. Paper Details

Side effects of selegiline (Eldepryl).

Author: WatersC H

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Selegiline can cause urinary retention in elderly patients with Parkinson's disease.
Paper Details　
Original Abstract of the Article :
Selegiline (Eldepryl), recently approved as an adjunct to levodopa-carbidopa (Sinemet), was administered to eight patients with Parkinson's disease in an open-label study. Many side effects were seen pertinent in particular to the elderly patient. Urinary retention was precipitated in two gentlemen....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/002383099200500105

データ提供：米国国立医学図書館（NLM）

Selegiline: A Promising Treatment for Parkinson's Disease with Potential Side Effects

Selegiline, a medication used to treat Parkinson's disease, has shown promise in improving symptoms and slowing disease progression. This study explores the potential side effects of selegiline, highlighting the need for cautious use in older patients. The study observed several side effects, particularly in elderly patients, including urinary retention. The researchers emphasize the importance of careful monitoring and consideration of potential side effects when prescribing selegiline for Parkinson's disease.

Navigating the Landscape of Parkinson's Disease Treatment

This study highlights the importance of considering both the benefits and risks associated with different treatment options for Parkinson's disease. While selegiline has demonstrated therapeutic potential, its use requires careful consideration of individual patient characteristics and potential side effects.

The Need for Individualized Treatment Plans for Parkinson's Disease

The research underscores the importance of individualized treatment plans for patients with Parkinson's disease. Careful monitoring, regular assessments, and a collaborative approach between patients and healthcare providers are crucial to optimize treatment outcomes and minimize potential side effects.

Dr. Camel's Conclusion

Imagine a weary camel, traversing a vast desert, seeking relief from the tremors of Parkinson's disease. Selegiline, like a precious oasis, offers a respite from the debilitating symptoms, but its benefits come with a reminder to proceed cautiously, mindful of potential side effects that could hinder the journey. This study underscores the importance of a balanced approach to treatment, ensuring a safe and comfortable passage through the challenges of Parkinson's disease.

Date :
  1. Date Completed 1992-06-04
  2. Date Revised 2019-10-28
Further Info :

Pubmed ID

1571071

DOI: Digital Object Identifier

10.1177/002383099200500105

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.